ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

OVIDREL
Infertility
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

OVIDREL Rx

Generic Name and Formulations:
Choriogonadotropin alfa (r-hCG) 250mcg/0.5mL; liq for SC inj.

Company:
EMD Serono, Inc.

Therapeutic Use:

Indications for OVIDREL:

Induction of final follicular maturation and early luteinization in infertile women as part of an Assisted Reproductive Technology (ART) program. Ovulation induction where infertility is not due to ovarian failure.

Adult:

250mg SC one day after last dose of follicle-stimulating agent, if adequate follicular development is evident, and only if there is no evidence of excessive ovarian response (e.g., significant ovarian enlargement, excessive estradiol production, multiple follicular development seen on ultrasound).

Children:

Not applicable.

Contraindications:

Ovarian enlargement and excessive follicular recruitment while undergoing menotropin therapy. Primary ovarian failure. Uncontrolled thyroid or adrenal dysfunction. Uncontrolled intracranial lesion (eg, pituitary tumor). Abnormal genital bleeding. Ovarian cyst or enlargement. Sex hormone-dependent tumors of reproductive system. Pregnancy (Cat.X).

Warnings/Precautions:

Do complete gynecological and endocrinological exam first. Cardiac or renal disease. Epilepsy. Migraine. Asthma. Nursing mothers.

Adverse Reactions:

Ovarian hyperstimulation syndrome (discontinue if occurs) or enlargement, ascites, pleural effusion, ovarian cyst rupture, abdominal pain, multiple births, arterial thromboembolism, headache, irritability, restlessness, depression, fatigue, edema, local reactions.

How Supplied:

Prefilled syringe—1

OVIDREL

  • 250mcg syringes (Qty:1)
  • appx. price $126.00
GoodRx

Sign Up for Free e-newsletters